$AKTSQ
Akoustis Technologies, Inc. Stock $aktsq

$aktsq Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022071579 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$5.865M	$5.566M	$1.868M
YoY Change	59.72%	197.97%	191.88%
Cost Of Revenue	$5.274M	$6.453M	$2.902M
YoY Change	15.94%	122.36%	75.88%
Gross Profit	$591.0K	-$887.0K	-$1.034M
YoY Change	-167.39%	-14.22%	2.38%
Gross Profit Margin	10.08%	-15.94%	-55.35%
Selling, General & Admin	$5.838M	$6.982M	$3.876M
YoY Change	13.45%	80.13%	32.29%
% of Gross Profit	987.82%
Research & Development	$7.645M	$10.10M	$7.974M
YoY Change	-16.83%	26.62%	24.98%
% of Gross Profit	1293.57%
Depreciation & Amortization	$2.642M	$2.450M	$1.473M
YoY Change	55.32%	66.33%	48.79%
% of Gross Profit	447.04%
Operating Expenses	$13.48M	$17.08M	$11.85M
YoY Change	-5.96%	44.13%	27.28%
Operating Profit	-$12.89M	-$17.97M	-$12.88M
YoY Change	-15.27%	39.44%	24.84%
Interest Expense	$116.0K	-$722.0K	$35.00K
YoY Change	314.29%	-2162.86%	-102.15%
% of Operating Profit
Other Income/Expense, Net	$1.737M	-$1.182M
YoY Change	6103.57%
Pretax Income	-$11.16M	-$19.15M	-$12.85M
YoY Change	-26.55%	49.02%	7.52%
Income Tax	$1.000K	-$57.00K
% Of Pretax Income
Net Earnings	-$11.16M	-$19.09M	-$12.85M
YoY Change	-26.91%	48.58%	7.52%
Net Earnings / Revenue	-190.21%	-342.99%	-687.85%
Basic Earnings Per Share	-$0.19	-$0.33	-$0.25
Diluted Earnings Per Share	-$0.19	-$0.33	-$249.8K
COMMON SHARES
Basic Shares Outstanding	57.47M shares	57.20M shares	51.44M shares
Diluted Shares Outstanding	57.58M shares	57.15M shares	51.44M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$46.57M	$60.66M	$75.68M
YoY Change	-30.98%	-19.84%	103.44%
Cash & Equivalents	$46.57M	$60.66M	$75.68M
Short-Term Investments
Other Short-Term Assets	$4.767M	$4.519M	$3.537M
YoY Change	50.95%	27.76%	135.8%
Inventory	$5.807M	$4.525M	$2.058M
Prepaid Expenses
Receivables	$3.171M	$2.976M	$1.352M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$60.31M	$72.68M	$82.63M
YoY Change	-20.02%	-12.03%	110.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$54.47M	$54.19M	$37.32M
YoY Change	34.04%	45.19%	54.86%
Goodwill	$8.051M	$8.051M
YoY Change
Intangibles	$8.267M	$8.639M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$71.00K	$71.00K	$11.00K
YoY Change	18.33%	545.45%	-97.25%
Total Long-Term Assets	$71.95M	$71.98M	$37.90M
YoY Change	22.57%	89.94%	51.58%
TOTAL ASSETS
Total Short-Term Assets	$60.31M	$72.68M	$82.63M
Total Long-Term Assets	$71.95M	$71.98M	$37.90M
Total Assets	$132.3M	$144.7M	$120.5M
YoY Change	-1.38%	20.03%	87.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.602M	$4.157M	$3.613M
YoY Change	43.12%	15.06%	416.14%
Accrued Expenses	$6.113M	$7.077M	$4.268M
YoY Change	17.72%	65.82%	29.33%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$8.775M	$12.65M	$7.881M
YoY Change	23.38%	60.5%	87.64%
LONG-TERM LIABILITIES
Long-Term Debt	$43.18M	$43.85M	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$1.226M	$1.472M	$245.0K
YoY Change	-5.18%	500.82%	-51.0%
Total Long-Term Liabilities	$44.41M	$45.33M	$245.0K
YoY Change	3334.42%	18400.41%	-99.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.775M	$12.65M	$7.881M
Total Long-Term Liabilities	$44.41M	$45.33M	$245.0K
Total Liabilities	$53.18M	$57.98M	$8.126M
YoY Change	195.92%	613.45%	-72.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$237.0M	-$225.9M
YoY Change
Common Stock	$58.00K	$57.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$79.08M	$86.69M	$112.4M
YoY Change
Total Liabilities & Shareholders Equity	$132.3M	$144.7M	$120.5M
YoY Change	-1.38%	20.03%	87.44%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$11.16M	-$19.09M	-$12.85M
YoY Change	-26.91%	48.58%	7.52%
Depreciation, Depletion And Amortization	$2.642M	$2.450M	$1.473M
YoY Change	55.32%	66.33%	48.79%
Cash From Operating Activities	-$11.23M	-$14.99M	-$12.69M
YoY Change	3.5%	18.14%	60.39%
INVESTING ACTIVITIES
Capital Expenditures	$3.153M	-$4.832M	-$5.729M
YoY Change	-144.45%	-15.66%	143.79%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$286.0K
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$3.153M	-$4.832M	-$5.443M
YoY Change	-71.78%	-11.23%	131.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	289.0K	0.000	5.489M
YoY Change	-97.91%	-100.0%	74.81%
NET CHANGE
Cash From Operating Activities	-11.23M	-$14.99M	-12.69M
Cash From Investing Activities	-3.153M	-$4.832M	-5.443M
Cash From Financing Activities	289.0K	0.000	5.489M
Net Change In Cash	-14.09M	-$19.82M	-12.64M
YoY Change	71.6%	56.8%	77.54%
FREE CASH FLOW
Cash From Operating Activities	-$11.23M	-$14.99M	-$12.69M
Capital Expenditures	$3.153M	-$4.832M	-$5.729M
Free Cash Flow	-$14.38M	-$10.16M	-$6.958M
YoY Change	282.86%	45.98%	25.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Huntersville
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	51157000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	8051000	usd
CY2022Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2022Q2	us-gaap	Goodwill Goodwill	8051000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8639000	usd
CY2022Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28078
CY2022Q3	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2022Q3	dei	Trading Symbol TradingSymbol	AKTS
CY2022Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8994000	usd
CY2022Q3	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1029000	usd
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	57469507	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	60664000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80485000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2976000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3793000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1126000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	4525000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	4094000	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	4519000	usd
CY2022Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	71000	usd
CY2022Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-1229046
CY2022Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	9805 Northcross Center Court,
CY2022Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
CY2022Q2	us-gaap	Assets Current AssetsCurrent	91731000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	54188000	usd
CY2022Q3	dei	Document Type DocumentType	10-Q
CY2022Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q3	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q3	dei	Entity File Number EntityFileNumber	001-38029
CY2022Q3	dei	Entity Registrant Name EntityRegistrantName	AKOUSTIS TECHNOLOGIES, INC.
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	3359000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	72684000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	279000	usd
CY2022Q3	us-gaap	Assets Assets	144662000	usd
CY2022Q2	us-gaap	Assets Assets	161338000	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10929000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	11204000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1268000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	855000	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	147000	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	286000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	305000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	313000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	12649000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	12658000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	43854000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	43731000	usd
CY2022Q3	akts	Contingent Consideration ContingentConsideration	624000	usd
CY2022Q2	akts	Contingent Consideration ContingentConsideration	591000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	732000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	811000	usd
CY2022Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	116000	usd
CY2022Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	117000	usd
CY2022Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	45326000	usd
CY2022Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	45250000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	57975000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	57908000	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57341047	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57341047	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57079347	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57079347	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	57000	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	57000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	312519000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	310171000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-225889000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-206798000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	86687000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	103430000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	144662000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	161338000	usd
CY2022Q3	us-gaap	Revenues Revenues	5566000	usd
CY2021Q3	us-gaap	Revenues Revenues	1868000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	6453000	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	2902000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-887000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	-1034000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10097000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7974000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6982000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3876000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	17079000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	11850000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-17966000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-12884000	usd
CY2022Q3	akts	Interestexpenses Income InterestexpensesIncome	743000	usd
CY2021Q3	akts	Interestexpenses Income InterestexpensesIncome	-35000	usd
CY2022Q3	us-gaap	Other Income OtherIncome	-14000	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-446000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-21000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1182000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	35000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-19148000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-12849000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-57000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-19091000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-12849000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57154393	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51436075	shares
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	103430000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2348000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-19091000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	86687000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	117410000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	5432000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2348000	usd
CY2021Q3	akts	Common Stock Issued For Exercise Of Warrants CommonStockIssuedForExerciseOfWarrants	24000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	33000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-12849000	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	112398000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-19091000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-12849000	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2450000	usd
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1473000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2348000	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2348000	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	143000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	97000	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	61000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-21000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	446000	usd
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1000	usd
CY2021Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	197000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-817000	usd
CY2021Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	182000	usd
CY2022Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	431000	usd
CY2021Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	668000	usd
CY2022Q3	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	952000	usd
CY2021Q3	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1223000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-569000	usd
CY2021Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1345000	usd
CY2021Q3	akts	Contract Liability ContractLiability	41000	usd
CY2022Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-88000	usd
CY2021Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-64000	usd
CY2022Q3	akts	Increase Decreasein Other Long Term Liabilities IncreaseDecreaseinOtherLongTermLiabilities	1000	usd
CY2022Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-138000	usd
CY2021Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-41000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14989000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12687000	usd
CY2022Q3	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	4832000	usd
CY2021Q3	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	5729000	usd
CY2021Q3	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	286000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4832000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5443000	usd
CY2021Q3	akts	Issuance Of Common Stock For Acquisition IssuanceOfCommonStockForAcquisition	-5432000	usd
CY2021Q3	akts	Proceeds From Employee Stock Purchase Plan ProceedsFromEmployeeStockPurchasePlan	33000	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	24000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5489000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-19821000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12641000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80485000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	88322000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60664000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	75681000	usd
CY2022Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	40000	usd
CY2022Q3	us-gaap	Stock Issued1 StockIssued1	686000	usd
CY2021Q3	us-gaap	Stock Issued1 StockIssued1	1992000	usd
CY2022Q3	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1. Organization</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Akoustis Technologies, Inc. (the “Company”) was incorporated on April 10, 2013, and effective December 15, 2016, the Company changed its state of incorporation to the State of Delaware. Through its wholly-owned subsidiary, Akoustis, Inc. (a Delaware corporation), the Company, headquartered in Huntersville, North Carolina, is focused on developing, designing, and manufacturing innovative radio frequency (“RF”) filter products for the wireless industry, including for products such as smartphones and tablets, cellular infrastructure equipment, Wi-Fi Customer Premise Equipment (“CPE”), and military and defense communication applications. Located between the device’s antenna and its digital backend, the RF front-end (“RFFE”) is the circuitry that performs the analog signal processing and contains components such as amplifiers, filters and switches. To construct the resonator devices that are the building blocks for its RF filters, the Company has developed a family of novel, high purity acoustic piezoelectric materials as well as a unique microelectromechanical system (“MEMS”) wafer process, collectively referred to as XBAW<sup>TM</sup> technology. The Company leverages its integrated device manufacturing (“IDM”) business model to develop and sell high performance RF filters using its XBAW<sup>TM</sup> technology. Filters are critical in selecting and rejecting signals, and their performance enables differentiation in the modules defining the RFFE. Additionally, through RFM Integrated Device, Inc. (“RFMi”), a wholly-owned subsidiary of Akoustis, Inc., the Company makes sales of complementary surface acoustic wave (“SAW”) resonators, RF filters, crystal (Xtal) resonators and oscillators, and ceramic products branded as “RFMi” products.</p>
CY2022Q3	us-gaap	Cash Cash	60700000	usd
CY2022Q3	akts	Working Capital WorkingCapital	60000000	usd
CY2022Q3	us-gaap	Liquidation Basis Of Accounting Remeasurement Gain Loss On Accrued Costs To Dispose Of Assets And Liabilities LiquidationBasisOfAccountingRemeasurementGainLossOnAccruedCostsToDisposeOfAssetsAndLiabilities	48000000	usd
CY2021Q3	akts	Closing Contract Assets ClosingContractAssets	783000	usd
CY2022Q3	akts	Total Revenue With Customers TotalRevenueWithCustomers	5566000	usd
CY2021Q3	akts	Total Revenue With Customers TotalRevenueWithCustomers	1868000	usd
CY2022Q3	akts	Contract Assets ContractAssets	908000	usd
CY2022Q3	akts	Contract Liability ContractLiability	286000	usd
CY2022Q3	akts	Closing Contract Assets ClosingContractAssets	1661000	usd
CY2022Q3	akts	Closing Contract Liability ClosingContractLiability	147000	usd
CY2022Q3	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-753000	usd
CY2022Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-139000	usd
CY2021Q3	akts	Contract Assets ContractAssets	411000	usd
CY2021Q3	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-372000	usd
CY2021Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-41000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	286000	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	67000	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1227000	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1077000	usd
CY2022Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1426000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1061000	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1872000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1956000	usd
CY2022Q3	akts	Total Inventories TotalInventories	4525000	usd
CY2022Q2	akts	Total Inventories TotalInventories	4094000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	73543000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	68431000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19355000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17274000	usd
CY2022Q3	akts	Total Property Plant And Equipment Net TotalPropertyPlantAndEquipmentNet	54188000	usd
CY2022Q2	akts	Total Property Plant And Equipment Net TotalPropertyPlantAndEquipmentNet	51157000	usd
CY2022Q2	akts	Accrued Goods Received Not Invoiced AccruedGoodsReceivedNotInvoiced	1472000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	2100000	usd
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	1500000	usd
CY2022Q3	us-gaap	Assets Disposed Of By Method Other Than Sale In Period Of Disposition Gain Loss On Disposition1 AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionGainLossOnDisposition1	11700000	usd
CY2022	us-gaap	Assets Disposed Of By Method Other Than Sale In Period Of Disposition Gain Loss On Disposition1 AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionGainLossOnDisposition1	14500000	usd
CY2022Q2	akts	Effect Of Exchange Rates On Cash And Cash Equivalents EffectOfExchangeRatesOnCashAndCashEquivalents	3500000	usd
CY2022Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1100000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.30	pure
CY2022Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	446000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	3682000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	13000000	usd
CY2022	us-gaap	Earnings Per Share Diluted Pro Forma Adjustment EarningsPerShareDilutedProFormaAdjustment	-0.25
CY2022Q3	us-gaap	Goodwill Gross GoodwillGross	8100000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4157000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3630000	usd
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3128000	usd
CY2022Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4641000	usd
CY2022Q3	akts	Accrued Goods Received Not Invoiced AccruedGoodsReceivedNotInvoiced	1079000	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2565000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1461000	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	10929000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	11204000	usd
CY2022Q3	akts	Contractual Interest ContractualInterest	660000	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	143000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.68
CY2022Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1168000	usd
CY2021Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1232000	usd
CY2022Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1181000	usd
CY2021Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1116000	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	2349000	usd
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	2348000	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	102000	usd
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	75000	usd
CY2022Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1029000	usd
CY2022Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1126000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	305000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	313000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	732000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	811000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M8D
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y5M1D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1003	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1003	pure
CY2022Q3	akts	Future Lease Payments Term FutureLeasePaymentsTerm	P5Y
CY2022Q3	akts	Total Common Stock Equivalents Shares TotalCommonStockEquivalentsShares	12395567	shares
CY2021Q3	akts	Total Common Stock Equivalents Shares TotalCommonStockEquivalentsShares	3014486	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0301	pure
CY2022Q3	akts	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Measurements Expected Debt Yield ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueMeasurementsExpectedDebtYield	0.454	pure
CY2022Q2	akts	Operating Leases Future Minimum Payment Due Current OperatingLeasesFutureMinimumPaymentDueCurrent	296000	usd
CY2022Q2	akts	Operating Leases Future Minimum Payment Due In Two Years OperatingLeasesFutureMinimumPaymentDueInTwoYears	366000	usd
CY2022Q2	akts	Operating Leases Future Minimum Payment Due In Three Years OperatingLeasesFutureMinimumPaymentDueInThreeYears	356000	usd
CY2022Q2	akts	Operating Leases Future Minimum Payment Due In Four Year OperatingLeasesFutureMinimumPaymentDueInFourYear	199000	usd
CY2022Q2	akts	Operating Leases Future Minimum Payment Due OperatingLeasesFutureMinimumPaymentDue	1217000	usd
CY2022Q2	akts	Lessee Operating Leases Liability Undiscounted Excess Amount LesseeOperatingLeasesLiabilityUndiscountedExcessAmount	-180000	usd
CY2022Q2	akts	Lessee Operating Leases Liability Payments Due LesseeOperatingLeasesLiabilityPaymentsDue	1037000	usd
CY2018Q1	akts	Ontario County Industrial Development Authority Agreement Description OntarioCountyIndustrialDevelopmentAuthorityAgreementDescription	Pursuant to the Agreements, the Company will lease for $1.00 annually to the OCIDA an approximately 9.995 acre parcel of land in Canandaigua, New York, together with the improvements thereon (including the Company’s New York fabrication facility), and transfer title to certain related equipment and personal property to the OCIDA (collectively, the “Facility”).
CY2018Q1	akts	Tax Savings Agreement Expire Date TaxSavingsAgreementExpireDate	The Company estimates substantial tax savings during the term of the Agreements, which expire on December 31, 2028.
CY2018Q1	akts	Aggregate Principal Amount AggregatePrincipalAmount	12000000	usd
CY2022Q3	akts	Payments For Lease Benefits PaymentsForLeaseBenefits	300000	usd
CY2022Q3	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1892000	usd
CY2022Q3	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	3007000	usd
CY2022Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	4899000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1446000	usd
CY2022Q2	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	3028000	usd
CY2022Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	4474000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1446000	usd
CY2022Q3	us-gaap	Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions	446000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1892000	usd
CY2022Q3	akts	Fair Value Measurement Of Revenue Volatility FairValueMeasurementOfRevenueVolatility	0.30	pure
CY2022	akts	Fair Value Measurement Of Revenue Volatility FairValueMeasurementOfRevenueVolatility	0.30	pure
CY2022Q3	akts	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisAssetValue	3028000	usd
CY2022Q3	akts	Change In Fair Value Of Convertible Note Derivatives ChangeInFairValueOfConvertibleNoteDerivatives	-21000	usd
CY2022Q3	akts	Fair Value Measurement Ending Balance FairValueMeasurementEndingBalance	3007000	usd
CY2022Q3	us-gaap	Share Price SharePrice	2970
CY2022Q2	us-gaap	Share Price SharePrice	3700
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.70	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.70	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0409	pure
CY2021Q3	akts	Increase Decreasein Other Long Term Liabilities IncreaseDecreaseinOtherLongTermLiabilities		usd
CY2021Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q2	akts	Operating Leases Future Minimum Payment Due Thereafter OperatingLeasesFutureMinimumPaymentDueThereafter		usd
CY2022	akts	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Measurements Expected Debt Yield ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueMeasurementsExpectedDebtYield	0.415	pure
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y8M12D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q3	akts	Initial Fair Value Of Contingent Consideration InitialFairValueOfContingentConsideration		usd
CY2022Q3	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures		usd
CY2022Q3	akts	Initial Fair Value Of Change In Control Provision In Convertible Note InitialFairValueOfChangeInControlProvisionInConvertibleNote		usd
CY2022Q3	dei	Amendment Flag AmendmentFlag	false
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51436075	shares
CY2021Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1		usd
CY2022Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001584754

Files In Submission

Name	View Source	Status
0001213900-22-071579-index-headers.html	Edgar Link	pending
0001213900-22-071579-index.html	Edgar Link	pending
0001213900-22-071579.txt	Edgar Link	pending
0001213900-22-071579-xbrl.zip	Edgar Link	pending
akts-20220930.xsd	Edgar Link	pending
f10q0922ex3-5_akoustis.htm	Edgar Link	pending
f10q0922ex31-1_akoustis.htm	Edgar Link	pending
f10q0922ex31-2_akoustis.htm	Edgar Link	pending
f10q0922ex32-1_akoustis.htm	Edgar Link	pending
f10q0922ex32-2_akoustis.htm	Edgar Link	pending
f10q0922_akoustis.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
akts-20220930_cal.xml	Edgar Link	unprocessable
akts-20220930_pre.xml	Edgar Link	unprocessable
akts-20220930_lab.xml	Edgar Link	unprocessable
akts-20220930_def.xml	Edgar Link	unprocessable
f10q0922_akoustis_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AKTSQ
Akoustis Technologies, Inc. Stock $aktsq

2022 Q4 Form 10-Q Financial Statement

#000121390022071579 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKTSQ Akoustis Technologies, Inc. Stock $aktsq

2022 Q4 Form 10-Q Financial Statement

#000121390022071579 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKTSQ
Akoustis Technologies, Inc. Stock $aktsq